• 1
    Stuart KA, Fletcher LM, Clouston AD, Lynch SV, Purdie DM, Kerlin P, Crawford DH. Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation. HEPATOLOGY 2000; 32: 12001207.
  • 2
    Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882888.
  • 3
    Brandhagen DJ, Alvarez W, Therneau TM, Kruckeberg KE, Thibodeau SN, Ludwig J, Porayko MK. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. HEPATOLOGY 2000; 31: 456460.
  • 4
    Duane P, Raja KB, Simpson RJ, Peters TJ. Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol 1992; 27: 539544.
  • 5
    Williams R, Williams HS, Scheuer PJ, Pitcher CS, Loiseau E, Sherlock S. Iron absorption and siderosis in chronic liver disease. Q J Med 1967; 141: 151166.
  • 6
    Friedman BI, Schaefer JW, Schiff L. Increased iron59 absorption in patients with hepatic cirrhosis. J Nucl Med 1966; 7: 594602.
  • 7
    Conrad ME, Berman A, Crosby WH. Iron kinetics in Laennec's cirrhosis. Gastroenterology 1962; 43: 385390.
  • 8
    Callender ST, Malpas JS. Absorption of iron in cirrhosis of liver. BMJ 1963; 2: 15161518.
  • 9
    Deller DJ. Iron59 absorption measurements by whole body counting: studies in alcoholic cirrhosis, hemochromatosis and pancreatitis. Am J Dig Dis 1965; 10: 249258.
  • 10
    Olatunbosun D, Ludwig J, Corbett WE, Simon JB, Valberg LS. Significance of alterations in iron absorption in patients with portal cirrhosis. Gastroenterology 1970; 59: 188199.
  • 11
    Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341: 19861995.
  • 12
    Fleming MD, Trenor CC, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrews NC. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997; 16: 383386.
  • 13
    Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482488.
  • 14
    McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 2001; 291: 17551759.
  • 15
    McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000; 5: 299309.
  • 16
    Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000; 275: 1990619912.
  • 17
    Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000; 403: 776781.
  • 18
    Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999; 21: 195199.
  • 19
    Zoller H, Koch RO, Theurl I, Obrist P, Pietrangelo A, Montosi G, Haile DJ, et al. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 2001; 120: 14121419.
  • 20
    Zoller H, Pietrangelo A, Vogel W, Weiss G. Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 1999; 353: 21202123.
  • 21
    Rolfs A, Bonkovsky HL, Kohlroser JG, McNeal K, Sharma A, Berger UV, Hediger MA. Intestinal expression of genes involved in iron absorption in humans. Am J Physiol Gastrointest-Liver Physiol 2002; 282: G598607.
  • 22
    Stuart KA, Anderson GJ, Frazer DM, Powell LW, McCullen M, Fletcher LM, Crawford DH. Duodenal expression of iron transport molecules in untreated haemochromatosis subjects. Gut 2003; 52: 953959.
  • 23
    Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 249251.
  • 24
    Pascoe A, Kerlin P, Steadman C, Clouston A, Jones D, Powell L, Jazwinska E, et al. Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation. Gut 1999; 45: 301305.
  • 25
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646649.
  • 26
    Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464470.
  • 27
    Searle SJ, Kerr KJ, Halliday JW, Powell L. Iron storage disease. In: MacSweenRNM, AnthonyPP, ScheuerPJ, BurtAD, PortmanBC, eds. Pathology of the Liver. 3rd ed. Edinburgh: Churchill Livingstone, 1994: 219241.
  • 28
    Kelleher B, Barrett S, Ryan E, Sweeney M, Leyden J, O'Keane C, Crowe J. Iron depletion therapy in hereditary haemochromatosis results in significantly increased DMT1 but not Ireg1 mRNA levels by real time PCR [abstract]. HEPATOLOGY 2002; 36: 702A.
  • 29
    Frazer DM, Wilkins SJ, Becker EM, Vulpe C, McKie AT, Trinder D, Anderson GJ. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 2002; 123: 835844.
  • 30
    Greenberg MS, Strohmeyer G, Hine GJ, Keene WR, Curtis G, Chalmers TC. Studies in iron absorption. III. Body radioactivity measurements of patients with liver disease. Gastroenterology 1964; 46: 651661.
  • 31
    Jandl JH. The anemia of liver disease: observations on its mechanism. J Clin Invest 1955; 34: 390404.
  • 32
    Cooper RA. Hemolytic syndromes and red cell membrane abnormalities in liver disease. Semin Hematol 1980; 17: 103112.
  • 33
    Conn HO. Portacaval anastomosis and hepatic hemosiderin deposition: a prospective, controlled investigation. Gastroenterology 1972; 62: 6172.
  • 34
    Adams PC, Bradley C, Frei JV. Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis. HEPATOLOGY 1994; 19: 101105.
  • 35
    Baker JA, Cohen M. Development of hemosiderosis after side-to-side portacaval shunting. Gastroenterology 1972; 63: 491494.
  • 36
    Celada A, Rudolf H, Donath A. Effect of a single ingestion of alcohol on iron absorption. Am J Hematol 1978; 5: 225237.
  • 37
    Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 78067810.
  • 38
    Krause A, Neitz S, Magert HJ, Schulz AAA, Forssmann WG, Schulz-Knappe P, Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000; 480: 147150.
  • 39
    Nicolas G, Bennoun M, Porteu A, Matiret S, Beaumont C, Grandchamp B, Sirito M, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002; 99: 45965601.
  • 40
    Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 2002; 100: 37763781.
  • 41
    Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brisoot P, Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001; 276: 78117819.